| [1] |
Bruix J, Castells A, Bosch J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure[J]. Gastroenterology, 1996, 111(4): 1018-1022.
|
| [2] |
Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation[J]. Hepatology, 1999, 30(6):1434-1440.
|
| [3] |
Ishizawa T, Hasegawa K, Aoki T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma[J]. Gastroenterology, 2008, 134(7):1908-1916.
|
| [4] |
Cucchetti A, Ercolani G, Vivarelli M, et al. Is portal hypertensiona contraindication to hepatic resection?[J]. Ann Surg, 2009, 250(6): 922-928.
|
| [5] |
Berzigotti A, Reig M, Abraldes JG, et al. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis[J]. Hepatology, 2015, 61(2):526-536.
|
| [6] |
Yang T, Lau WY, Zhang H, et al. Should surgery be carried out in patients with hepatocellular carcinoma with portal hypertension?[J]. Hepatology, 2015, 62(3):976.
|
| [7] |
Zhong JH, Li LQ. Portal hypertension should not bea contraindication of hepatic resection to treat hepatocellular carcinoma with compensated cirrhosis[J]. Hepatology, 2015, 62(3):977-978.
|
| [8] |
Cucchetti A, Cescon M, Pinna AD. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. more doubts than clarity[J]. Hepatology, 2015, 62(3):976-977.
|
| [9] |
Qiu J, Zheng Y, Shen J, et al. Resection versus ablation in hepatitis B virus-related hepatocellular carcinoma patients with portal hypertension: a propensity score matching study[J]. Surgery, 2015, 158(5):1235-1243.
|
| [10] |
杨平华，屈淑平，程张军，等．肝癌伴门静脉高压症的肝切除术[J]．肝脏，2012，17(9): 626-629.
|
| [11] |
Zhong JH, Li H, Xiao N, et al. Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension[J]. PLoS One, 2014, 9(9):e108755.
|
| [12] |
He W, Zeng Q, Zheng Y, et al. The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis[J]. BMC Cancer, 2015(15):263.
|
| [13] |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2):87-108.
|
| [14] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
|
| [15] |
Kao WY, Su CW, Chau GY, et al. A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery[J]. World J Surg, 2011, 35(4):858-867.
|
| [16] |
Boleslawski E, Petrovai G, Truant S, et al. Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis[J]. Br J Surg, 2012, 99(6):855-863.
|
| [17] |
Stremitzer S, Tamandl D, Kaczirek K, et al. Value of hepatic venous pressure gradient measurement before liver resection for hepatocellular carcinoma[J]. Br J Surg, 2011, 98(12):1752-1758.
|
| [18] |
Fang KC, Su CW, Chiou YY, et al. The impact of clinically significant portal hypertension on the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation: a propensity score matching analysis[J]. Eur Radiol, 2017, 27(6):2600-2609.
|
| [19] |
Berzigotti A, Piscaglia F, EFSUMB Education and Professional Standards Committee. Ultrasound in portal hypertension--part 2-and EFSUMB recommendations for the performance and reporting of ultrasound examinations in portal hypertension[J]. Ultraschall Med, 2012, 33(1):8-32.
|
| [20] |
宋珂达，姜洪池．门静脉压力无创测定应给予重视[J/CD]．中华普通外科学文献（电子版），2018，12(6):373-375.
|
| [21] |
Llop E, Berzigotti A, Reig M, et al. Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors[J]. J Hepatol, 2012, 56(1):103-108.
|
| [22] |
Vizzutti F, Arena U, Romanelli RG, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis[J]. Hepatology, 2007, 45(5):1290-1297.
|
| [23] |
Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade[J]. J Clin Oncol, 2015, 33(6):550-558.
|
| [24] |
Pind ML, Bendtsen F, Kallemose T, et al. Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis[J]. Eur J Gastroenterol Hepatol, 2016, 28(8):948-954.
|
| [25] |
董家鸿，唐茂盛，张文智，等．精准肝脏外科理念和技术对大范围肝切除围手术期安全性的影响[J]．中华消化外科杂志，2013，12(5):344-351.
|
| [26] |
Hughes MJ, Ventham NT, Harrison EM, et al. Central venous pressure and liver resection: a systematic review and meta-analysis[J]. HPB, 2015, 17(10): 863-871.
|